- Novel Agents in the Treatment of Chronic Lymphocytic Leukemia
-
Choi CW
- KMID: 2082583
- Korean J Med.
- 2015 Mar;88(3):258-261.
- doi: 10.3904/kjm.2015.88.3.258
Chronic lymphocytic leukemia (CLL) is an indolent B-cell leukemia, and the most common leukemia in the Western world. While CLL is currently a rare leukemia type in Korea, the prevalence... -
- CITED
-
- Close
- SHARE
-
- Close
- A case report of near-triploid in adult acute lymphocytic leukemia
-
Jun CK, Cha JY, Oh HM, Shin YS, Kim YK, Kim SY, Kim YJ, Park BY, Cho MK, Lee GJ, Lee KI, Lee EH
- KMID: 1601339
- Korean J Med.
- 2001 Aug;61(2):190-194.
In addition to age, white cell count and immunophenotype, karyotype has been reported to be one of the important prognostic factors in acute lymphocytic leukemias.Furthermore 70 percent of patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case Report of Mantle Cell Lymphoma in Leukemic Phase
-
Hwang MW, Choi HK, Yoon SY, Kim AR, Lee KN
- KMID: 2089440
- Korean J Clin Pathol.
- 1997 Aug;17(4):539-546.
Recently, we experienced a patient with a B cell leukemia which could not be classified as chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PL) or follicular lymphoma in leukemic phase. He... -
- CITED
-
- Close
- SHARE
-
- Close
- Fludarabine and Rituximab in Relapsed or Refractory Hairy Cell Leukmia Variant: A Case Report and Review of Literature
-
Lee JW, Choi YM, Yang JY, Han SM, Kim BS, Nam SH
- KMID: 2442557
- Kosin Med J.
- 2018 Dec;33(3):438-445.
- doi: 10.7180/kmj.2018.33.3.438
Hairy cell leukemia (HCL) is a rare chronic B cell leukemia morphologically characterized by cells with an abundant cytoplasm and hair-like projections that can be found in the peripheral blood... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic Lymphocytic Leukemia-Era of Targeted Therapy
-
Shin DY, Kim I
- KMID: 2267805
- Korean J Med.
- 2013 Aug;85(2):141-153.
Chronic lymphocytic leukemia (CLL) is a unique indolent B-cell leukemia which is rare in Korea. Many patients with early stage CLL do not require immediate treatment, while those with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Silencing the PIK3CA Gene Enhances the Sensitivity of Childhood Leukemia Cells to Chemotherapy Drugs by Suppressing the Phosphorylation of Akt
-
Liang X, Xin X, Qi D, Fu C, Ding M
- KMID: 2431635
- Yonsei Med J.
- 2019 Feb;60(2):182-190.
- doi: 10.3349/ymj.2019.60.2.182
PURPOSE: This study aimed to investigate the effects of PIK3CA on the sensitivity of acute B lymphocytic leukemia cells (Nalm-6 cells) to chemotherapy drugs. MATERIALS AND METHODS: Children's normal B lymphocytes... -
- CITED
-
- Close
- SHARE
-
- Close
- JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma
-
Kim MS, Park CJ, Cho YU, Jang S, Seo EJ, Park CS, Huh J, Im HJ, Seo JJ, Yoon DH, Suh C
- KMID: 2457486
- Ann Lab Med.
- 2020 Jan;40(1):1-6.
- doi: 10.3343/alm.2020.40.1.1
BACKGROUND: JL1, a CD43 epitope and mucin family cell surface glycoprotein, is expressed on leukemic cells. An anti-JL1 antibody combined with a toxic substance can have targeted therapeutic effects against... -
- CITED
-
- Close
- SHARE
-
- Close
- Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers
-
Park SR
- KMID: 2150754
- Immune Netw.
- 2012 Dec;12(6):230-239.
- doi: 10.4110/in.2012.12.6.230
Activation-induced cytidine deaminase (AID) is an enzyme that is predominantly expressed in germinal center B cells and plays a pivotal role in immunoglobulin class switch recombination and somatic hypermutation for... -
- CITED
-
- Close
- SHARE
-
- Close
